key: cord-0881227-ng5az79z
authors: Llorente Ayuso, Lucía; Torres Rubio, Pedro; Beijinho do Rosário, Rafael Fernando; Giganto Arroyo, María Luisa; Sierra-Hidalgo, Fernando
title: Bickerstaff encephalitis after COVID-19
date: 2020-09-03
journal: J Neurol
DOI: 10.1007/s00415-020-10201-1
sha: 093d08bd2fddaff8763b3070f5bb1b46750ad514
doc_id: 881227
cord_uid: ng5az79z

nan

myoclonus in the face and both arms could be induced by sound and tactile stimuli.

Upon admission, PCR to SARS-CoV-2 was negative. Brain magnetic resonance imaging (MRI) showed hyperintense lesions in the caudal vermis and right flocculus, and contrast enhancement was observed in the floor of the fourth ventricle ( Fig. 1 ). An electroencephalogram was normal. The CSF examination then showed a leukocyte count of 0/mm 3 , glucose level of 70 mg/dl, protein level of 41 mg/dl, sterile cultures, IgG index of 0.5, and the absence of oligoclonal bands. Blood serological tests for HIV and Treponema pallidum were negative, as well as IgM for Varicella-zoster virus, Epstein Barr virus, Cytomegalovirus, Mycoplasma pneumoniae, and Borrelia burgdorferi. Anti-glutamic acid decarboxylase, antithyroid, anti-transglutaminase, and antinuclear antibodies all tested negative. Electromyography was not performed. Anti-Hu, anti-Yo, anti-Ri, anti-CV2, anti-Ma2, and anti-amphiphysin antibodies were absent in serum and CSF.

Once other causes were excluded, a post-infectious, immune-mediated rhomboencephalitis was suspected, and the patient was treated with IV methylprednisolone 1,000 mg daily for five days, followed by 1 mg/kg/day of PO prednisone. A significant improvement existed within days, with resolution of bradypsychia, nystagmus, Babinski sign, and myoclonus, and improvement of ataxia.

Anti-GD1a IgG antibodies (immunoblot analysis) tested positive in serum. A follow-up MRI performed on day 24 after admission revealed a significant decrease of the vestibulocerebellar hyperintensities, and the patient was discharged. Only a very mild unsteadiness persisted in a followup visit two months later.

This patient had an acute brainstem and cerebellar dysfunction that appeared within several days after getting over COVID-19. The presence of a previous viral disease, pyramidal tract involvement, brainstem enhancement on MRI, and positive testing for anti-GD1a antibodies led to a diagnosis of Bickerstaff brainstem encephalitis (BBE) despite the absence of ophthalmoplegia [1, 2] .

Anti-GD1a antibodies are well recognized in BBE, and cerebellum may be also involved in antiganglioside antibodies syndromes [3, 4] . Increasing evidence suggests that an enhanced immune response is involved in the physiopathology of a wide range of complications of SARS-CoV-2 infection, including neurological disorders [5] . Guillain-Barré syndrome, Miller Fisher syndrome, acute necrotizing encephalitis, myelitis, acute disseminated encephalomyelitis (ADEM), and myasthenia gravis have been reported after COVID-19 [6] [7] [8] [9] [10] [11] [12] . As in the described patient, immunotherapy seemed to have a beneficial effect in several of these cases. BBE widens the spectrum of para-or post-infectious neurological disorders related to COVID-19.

Funding None.

Conflicts of interest On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards This report belongs to the COVID-19@Vallecas cohort. The study was approved by the Hospital Universitario Infanta Leonor ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Availability of data and material Data of the reported case is presented within the manuscript. Fig. 1 Brain MRI findings. a and b, high signal intensity of the right flocculus and the nodulus on FLAIR images. c weak restriction of the nodulus on diffusion-weighted images. d lineal gadolinium enhancement of dorsal medulla on T1-weighted images

Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia

Bickerstaff brainstem encephalitis: more common than we think?

Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome

Acute vestibular syndrome associated with anti-GQ1b antibody

Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology

Guillain-Barré syndrome related to COVID-19 infection

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features

COVID-19-associated acute disseminated encephalomyelitis (ADEM)

Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry

The emerging spectrum of COVID-19 neurology: clinical radiological and laboratory findings

Myasthenia gravis associated with SARS-CoV-2 infection